Markets:

Overview

News

Currencies

International

Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

5.580 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Puma Biotechnology Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Puma Biotechnology's Earnings Outlook ↗

November 02, 2022

Puma Biotechnology (NASDAQ:PBYI) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Puma...

Via Benzinga

Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium

October 27, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

October 20, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer ↗

September 21, 2022

Via Benzinga

Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor

September 20, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022

September 11, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 06, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

September 02, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

August 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Second Quarter 2022 Financial Results

August 04, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results

July 21, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

July 06, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

June 07, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting

June 06, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting

June 04, 2022

From Puma Biotechnology, Inc.

Via Business Wire

69 Biggest Movers From Friday ↗

June 06, 2022

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...

Via Benzinga

Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting

May 26, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

May 11, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports First Quarter 2022 Financial Results

May 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting

April 27, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results

April 21, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

April 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 03, 2022

Gainers Puma Biotechnology (NASDAQ:PBYI) ...

Via Benzinga

The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO ↗

March 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...

Via Benzinga

Puma Biotechnology's Earnings: A Preview ↗

March 02, 2022

Puma Biotechnology (NASDAQ:PBYI) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight ↗

February 27, 2022

Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first...

Via Benzinga

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results

February 16, 2022

From Puma Biotechnology, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

All News about Puma Biotechnology Inc - Common Stock

Starting at $3.75/week.

Subscribe Today